Verition Fund Management
SRRA

Verition Fund Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Verition Fund Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-32,662
Closed -$1.8M – 3353
2022
Q2 		$1.8M Buy
+32,662
New +$1.71M 0.04% 722

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Verition Fund Management's SRRA Position: Q3 2022 in Review

Verition Fund Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 32,662 shares — an estimated $1.8M sold.

Verition Fund Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $1.8M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Verition Fund Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Verition Fund Management sold 32,662 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.8M.
  • Verition Fund Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Verition Fund Management's Sierra Oncology, Inc. Common Stock position peaked at $1.8M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Verition Fund Management's 13F filing for Q3 2022, filed 14 Nov 2022.